FICO Shorts Ease but Analysts Keep Cutting Targets

FICO enters the second week of August with short sellers visibly retreating, but the analyst community still reassessing what the stock is worth after last month's guidance shock.

The clearest development this week is the sharp pullback in short interest. Estimated short interest fell 16.8% over the five days to August 11, dropping to 7.7% of the free float — down from above 10% flagged in the previous note and now at its lowest level in nearly six weeks. That is a material move in one week. It signals that some traders who built bearish positions into and around the July 30 guidance miss are covering, not adding. The borrow market reinforces this read: cost to borrow is still negligible at 0.48%, and availability has widened sharply — lending pool availability now stands at 423% of estimated short interest, up 25% on the week and the loosest it has been since early August 2025. There is no sign of squeeze mechanics here, just orderly covering.

Options positioning tells a similarly un-dramatic story. The put/call ratio at 0.81 is modestly below its 20-day average of 0.84 — fractionally more call-leaning than usual, with a z-score of -0.85. That is a notable contrast to the defensive hedging that preceded the July 29 earnings print. The options market has relaxed, not panicked, in the face of the continued price weakness.

The analyst story is where the real tension sits. Targets have been moving in one direction: lower. UBS trimmed its target to $1,130 from $1,200 today, maintaining Neutral. Barclays cut to $1,700 from $1,950 on Monday, keeping Outperform. Those two moves follow RBC's post-earnings chop from $2,400 to $1,525 and the Wolfe Research downgrade to Peer Perform at the start of the month. The dispersion in targets — from $1,130 at the cautious end to $1,700 at the optimistic end — is unusually wide and reflects genuine disagreement about what the guidance miss implies for FICO's medium-term trajectory. The consensus mean target of $1,473 implies roughly 42% upside from the current $1,038 close, but that figure is being dragged by older, higher targets that have not yet been revised. The ORTEX short score has eased to 57 from 63 just two weeks ago, consistent with the short-covering trend rather than any fresh bearish conviction. Bulls point to FICO's entrenched dominance in credit scoring and the buyback program supporting earnings per share; bears flag VantageScore's regulatory approval for GSE mortgages and the risk that FY guidance disappointment is structural rather than one-quarter noise.

The institutional holder picture adds one point of interest. Capital Research and Management holds 11.9% of shares — the largest single institutional position — and reported adding nearly one million shares as of May 31. That is a significant conviction position built before the earnings shock. Whether that holding has been trimmed in subsequent weeks is not yet reflected in available filing data, but it represents a meaningful overhang of informed money that entered at higher prices.

The post-earnings price action has been severe: the stock fell 14.7% the day after the July 29 print and another 8.3% in the session that followed. Year-to-date the decline now stands around 38%. The stock is at $1,038, down just under 1% on the week — a relative stabilisation compared to the prior week's 18% collapse. The next scheduled earnings event is November 6, and between now and then the debate will centre on whether July's guidance miss was a reset or the opening move in a longer derating.

What to watch: whether the target-cutting cycle among remaining bulls — particularly RBC and Barclays, both of whom still hold positive ratings despite meaningful target reductions — stabilises or continues as the stock trades well below even the revised figures.